title: Dolutegravir monotherapy: when should clinical practice be clinical research?
authors.affiliation: Southwest CARE Center, Santa Fe, NM, USA.|Johns Hopkins University School of Medicine, Baltimore, MD, USA.
authors.forename: Joel
authors.initials: J
authors.lastname: Gallant
authors.affiliation: Johns Hopkins Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA.
authors.forename: Jeremy
authors.initials: J
authors.lastname: Sugarman
mesh_terms: D000328:Adult; D015331:Cohort Studies; D006678:HIV; D019428:HIV Integrase Inhibitors; D006575:Heterocyclic Compounds, 3-Ring; D006801:Humans; D010078:Oxazines; D010879:Piperazines; D011728:Pyridones; D000099226:Dolutegravir
chemical_list: D019428:HIV Integrase Inhibitors; D006575:Heterocyclic Compounds, 3-Ring; D010078:Oxazines; D010879:Piperazines; D011728:Pyridones; D000099226:Dolutegravir